Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg

Clinical trial NCT02662764 · COMPLETED

Trial details

NCT number: NCT02662764
Sponsor: Talphera, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate-to-severe Acute Pain

Start date: 2016-09-28
Primary completion: 2017-04-14
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.